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Recently, NIH has funded a center for autophagy research named the 
Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research 
Excellence, located at the University of New Mexico Health Science Center 
(UNM HSC), with aspirations to promote autophagy research locally, nationally, 
and internationally. The center has 3 major missions: (i) to support junior faculty 
in their endeavors to develop investigations in this area and obtain independent 
funding; (ii) to develop and provide technological platforms to advance  
autophagy research with emphasis on cellular approaches for high quality 
reproducible research; and (iii) to foster international collaborations through the 
formation of an International Council of Affiliate Members and through hosting 
national and international workshops and symposia. Scientifically, the AIM center 
is focused on autophagy and its intersections with other processes, with 





The purpose of this article is to inform the international autophagy research 
community about the establishment of a new center for autophagy research that 
we think will be a useful resource to the scientific community interested in 
fundamental and disease-related research on autophagy. The National Institutes 
of Health (NIH) Centers of Biomedical Research Excellence (CoBRE) program, 
of which the Autophagy, Inflammation, and Metabolism Center (AIM) is a part of 
and is funded by, has the mission to develop research capacity through several 
mechanisms housed within thematic centers focused on a multidisciplinary 
theme, such as autophagy, with cross-cutting implications for both fundamental 
science and translational research. The AIM center’s specific mission is to 
provide a national and international hub for advancement of autophagy research. 
This includes autophagy and its connections with other fundamental processes, 
often in disease contexts but also from the perspective of basic science. The 
initial and evolving processes for achieving these goals are multi-pronged as 
described below.  
 
Enabling junior investigators whose research is focused on autophagy as 
the central theme of the center 
The research-building mechanism that will have the most significance and 
financial impact through the AIM center is to provide multi-year funding support to 
junior faculty. This funding of individual projects is at a level equivalent to a 
typical NIH R01 project, or independent group leader funding, enabling junior 
investigators (usually starting Assistant Professors on a tenure track, referred to 
as mentored Principal Investigators, or “mPIs”) to develop their program 
sufficiently to be able to compete for their own independent R01-level funding. 
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This is done in a mentored and collaborative environment, further bolstered by 
high-end shared equipment core facilities, accessible initially without added cost 
to both mPIs and other AIM’s members. The mPIs are appointed for a specifc 
number of years (typically 3), after which they graduate. Upon graduation, former 
mPIs remain tightly associated with the center, maintaining their membership 
status, and transfer their experience to other active and new mPIs in the center; 
they retain the same space, which is usually provided by their home departments 
at the outset. An mPI’s graduation in turn triggers formal searches for new junior 
investigators, who are identified via local and external competitive searches and 
selection processes. Upon their selection, new mPIs are given their funding and 
access to facilities through the center and are integrated into the center’s 
activities.  
 
Building a broader community of scholars with interests focused on the 
central theme of autophagy research 
In addition to supporting junior investigators, the center provides an intellectual 
thematic hub for investigators at multiple stages of their career. This includes the 
scientific leadership of the center and other more senior investigators who play 
mentoring roles. These scientists are full members of the center along with the 
mPIs. Associate members join the center through the simple process of 
presenting their science in a seminar (physically given on the premises or 
remotely through teleconferencing), providing a brief synopsis (half a page) of 
their project and relatedness to the focal theme(s) of the AIM center, and their 
biosketch/cv. Upon receiving a formal vote by the scientific leadership (AIM’s 
executive committee), associate members are installed and obtain privileges to 
access scientific cores and join ongoing formal collaborative initiatives.  Whereas 
the use of AIM technological platforms housed in scientific cores, such as high-
content microscopy quantification of autophagy processes, may be most 
accessible locally, fixed and processed samples can be shipped from distant 
sites thus providing global access to the facility.   
 
External Advisory Board 
The AIM center has a national External Advisory Board (EAB), with the present 
members being distinguished US scientists: Dr. Beth Levine, UT Southwestern, 
Dallas, Chairperson of the EAB and a leading autophagy researcher; Dr. Vishva 
Dixit, Vice-President of Genentech and international authority on inflammation, 
Dr. Randal Kaufman, the director of the Degenerative Diseases Program, 
Neuroscience and Aging Center at Sanford Burnham Prebys Medical Discovery 
Institute, La Jolla; and Dr. Philipp Scherer, director of the Touchstone Diabetes 
Center at UT Southwestern, Dallas. The role of the EAB is to provide advice to 
the center director, assess the function of the AIM center annually and participate 
in selection and appointments of new mPIs. The composition of the EAB is 




International Council of Affiliate members: global cooperation in autophagy 
research 
The International Council of Affiliate Members (ICAM) is a key component of 
AIM, reaching out to the broader community of autophagy scholars across the 
globe. The role of ICAM is to participate in AIM activities, to foster international 
collaborations, and to engage in the exchange of ideas and technologies of 
relevance for autophagy research. The ICAM members provide their input 
through tele- and video-conferencing and participate in person in the symposia 
and workshops organized at the AIM center. The ICAM is composed of 
internationally renowned leaders in autophagy research or international 
authorities in other fields of key interest to the AIM center. The members come 
from nearly all continents including Africa, Asia, Australia, Europe, North 
America; and South America (Figure 1). The founding members of the ICAM are:  
Eric H. Baehrecke (USA), Christian Behrends (Germany), Francesco Cecconi 
(Italy, Denmark), Patrice Codogno (France), Guang-Chao Chen (Taiwan), Zvulun 
Elazar (Israel), Eeva-Liisa Eskelinen (Finland) Bernard Fourie (South Africa), 
Devrim Gozuacik (Turkey), Wanjin Hong (Singapore), Gokhan Hotamisligi (USA), 
Marja Jäättelä (Denmark), Terje Johansen (Norway), Eun-Kyeong Jo (South 
Korea), Gábor Juhász (Hungary), Daniel Klionsky (USA), Nicholas Ktistakis (UK), 
Adi Kimchi (Israel), Guido Kroemer (France, Sweden), Noboru Mizushima 
(Japan), Christian Münz (Switzerland), Kevin Ryan (UK), Fulvio Reggiori (The 
Netherlands), David Rubinsztein (UK), Kate Schroder (Australia), Anne 
Simonsen (Norway), Sharon Tooze (UK), Maria I. Vaccaro (Argentina), Tamotsu 
Yoshimori (Japan), Li Yu (China), and Hong Zhang (China).  It is anticipated that 
a subset of ICAM members will participate in person at the annual AIM meetings 
and/or workshops. The first such event is planned in 2019, in connection with the 
Keystone Symposium on autophagy taking place in Santa Fe, near the AIM 
center location. It is also expected that over time, the productive interactions 




The AIM center has 3 core facilities: (i) Administrative core; (ii) Autophagy 
scientific core (ASC); and (iii) Inflammation and metabolism core (IMC).  
 
The administrative core is composed of the leadership (Director and executive 
committee) from the ranks of scientists in different departments and schools at 
the UNM HSC. This ensures a broad local base of participants, which is an 
important aspect for the success of the AIM center. The center leadership is 
assisted by an internal advisory board, and by the EAB. The administrative core 
also provides mentoring infrastructure and evaluates progress of junior 
(mentored) PIs as well as the function and contributions of mentoring faculty.  A 
centerpiece for mentoring is an individualized development plan for each mPI, 
customized to the needs of each junior faculty member. The mPIs select a small 
subset from the list of offered core competencies. This list is supplemented by 
unique, custom developed training in consultations with their mentors. This 
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combination allows a high degree of personalization to enhance mPIs’ careers 
and funding success. It is also expected that these junior investigators will gain 
access to broad international expertise and collaborations via interactions with 
the ICAM members. 
 
The two technological cores, ASC and IMC, provide instrumentation designed 
not to duplicate but to complement the existing conventional facilities, e.g. flow 
cytometry, genomics, confocal microscopy, electron microscopy, animal, and 
high-throughput drug screening facilities, etc., available at UNM HSC. The ASC 
focuses on high content microscopy for adherent cells (Cellomics) and for cells in 
suspension (Amnis), to quantitatively analyze in a highly rigorous manner (and 
thus promote reproducibility in research) autophagic profiles as well as other 
subcellular structures and changes.  The IMC focuses on inflammatory (e.g. 
Amnis in its flow cytometry mode) and metabolic measurements (e.g. Seahorse, 
etc.). The AIM center has a development program to update and acquire new 
instruments over time. The instrumentation is covered by service contracts and 
appropriate user charges will be implemented in support of extended service 
contracts in the out years. The cores are supervised by core directors and daily 
operations (user scheduling, user training, and equipment maintenance) are 
carried out by the core technical director, with users following clearly defined and 
web-accessible standard operating procedures. Importantly, the principle model 
for access to core instrumentation by AIM members, associate members, and 
affiliated members is not based on charges during the first several years, but 
rather by establishing a membership user base, with any charges being 
implemented in the out years as described above or for external non-member 
users from the outset.  Because fixed specimens (e.g. cells in 96 well plates), 
can be shipped, AIM is prepared to provide service not just locally but also 
nationally and internationally via collaborative agreements. 
 
Modes of growing the base and promoting autophagy research  
The AIM center has pilot programs and announces Requests for Applications 
(RFA) that are offered at least twice a year. These can be themed or investigator 
initiated, depending on the RFA, but are focused on autophagy and its 
intersections with other areas. The pilots stimulate autophagy research locally. 
Another process is hiring faculty through a national/international search for 
tenure-track Assistant Professors. These are usually triggered upon graduation 
of an mPI, when she or he acquires independent R01 or equivalent funding. The 
corresponding funds, in the amount (depending on circumstances) close to an 
R01-level funding, are then transferred to newly appointed mPIs. Mentors and 
mentees are also encouraged to collaborate and publish together, which further 
expands autophagy research to include more senior investigators. Finally, 
international collaborations fostered through ICAM are expected to provide a 
home to and a role for ICAM affiliate members and intend to integrate the AIM 
center within the international community of autophagy scholars. 
 
Events, meetings, symposia and workshops 
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The AIM center has bi-weekly Tuesday AIM seminars (TAIMs). TAIMs are 
envisioned to be somewhat different than a conventional seminar series. First, 
formal presentations are 30 min, whereas the second half of an hour-long TAIM’s 
meeting is reserved for informal discussions and mingling. The presentations at 
TAIMs are a mix of work in progress with raw data, a venue for presentation by 
potential associate members, summary of technical advances and equipment 
capabilities organized by cores’ leadership, journal clubs, and a venue for 
progress presentations given by the mPIs.  
 
Every year, the AIM center plans an annual symposium, where AIM members 
and invited speakers present their work and seminars, whereas trainees present 
posters or give short platform talks. Some of the annual meetings will be 
formatted as workshops and will include both practical and theoretical 
components and will drawing on the pool of speakers from the ICAM and other 
sources. 
 
Dissemination of information  
Events at, and news from, AIM that are of general interest to the international 
autophagy community are disseminated through the AIM center via its web site 
(https://www.autophagy.center), Twitter (www.twitter.com/AIM_autophagy) and 
Facebook (www.facebook.com/aimautophagy).   Blog capabilities for active 
discussions are under development. 
 
Present and evolving research at the AIM center 
The research programs at the AIM center include mPIs funded projects centered 
on autophagy, but also addressing inflammation or metabolism as well as their 
interconnections. The more senior personnel have a diverse portfolio of research 
funded independently of the AIM center. Through collaborative efforts, it is 
expected that the majority of senior investigators will find synergy with the central 
theme of the center. Once mPIs “graduate” they remain as AIM members, and 
their role as contributors to the AIM center community of scholars is expected to 
remain permanent. Continued participation by former mPIs in AIM research 
activities, collaborations, and events and group activities will ensure continuing 
connection with AIM and support from AIM will depend on maintaining such 
relationships and collegiality.  New recruits at the level of Assistant Professors on 
tenure track will be brought into the system and their work will infuse the AIM 
center with evolving new directions that they will bring with them. This 
mechanism avoids stagnation and should ensure a dynamic research portfolio 
keeping up with the most recent research trends and technologies.  
 
Future of the AIM center 
The AIM center had a grand opening event in March 2018, with Randy 
Schekman delivering the keynote lecture, followed by a reception. Renovations 
of the floor on which AIM is located are underway. Two mPIs have already 
graduated, i.e. obtained their independent R01 grants, and faculty searches for 
new mPIs are underway. As noted above, the AIM symposium planned for 2019 
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will be associated with the autophagy Keystone Symposia meeting in Santa Fe. 
In other years, a subset of ICAM affiliate members will be invited for workshops 
or symposia. In some instances, there will be practical courses and 
demonstrations of new technologies. The AIM center is expected to contribute to 
the scientific progress in the area of autophagy, both fundamental and 
applied/translational, and enhance output and funding in the areas of autophagy, 
inflammation, and metabolism, through publications and funding, enabling junior 
investigators to achieve significant independent funding, and continuing 
replenishment of faculty ranks. It will strive to become a hub for national and 
international research in autophagy, enabling independent careers of junior 
faculty in a supportive, inviting and cooperative environment for which the 
international autophagy community has always been famous. Given that the 
mechanism of funding provides options for 3 phases each of 5 years in duration, 
the impact of the AIM center on the local, national and international scene may 
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Figure 1. Global distribution of AIM’s International Council of Affiliate members 
(ICAM). Initials, affiliate members; full names are given in the text. 
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